Drugs / Ad5-hGCC-PADRE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01972737 | Oct 2013 → Jun 2014 | colon carcinoma | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5-hGCC-PADRE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01972737 ↗ |
| Route | Intramuscular | “A single intramuscular dose (100 billion virus particles) of Ad5-hGCC-PADRE vaccine.” NCT01972737 ↗ |